Natural Alternatives (NAII) +19% Today on Recent Financials and Availability of its Patented Product Line

Destiny A. Lopez  |

Natural Alternatives (NAII), a formulator and manufacturer of customized nutritional supplements, is seeing an impressive jump in the market today. Up nearly twenty percent, the increase follows the recent release of the company’s fiscal 2016 Q4 results.

The overwhelmingly positive report cites a 32.7% increase in 2016 net sales, along with the following:

  • Q4 2016 Net income totaled $3.4 million, an increase compared to $1 million in Q4 2015.
  • By end of Q4 2016, cash totaled $19.7 million and working capital totaled $36.7 million. Both demonstrate increases when compared to $18.6 million and $34.5 million, respectively.
  • CarnoSyn® beta-alanine royalty, licensing and raw material sales revenue totaled $21.8 million in fiscal 2016, a 138.3% increase when compared to $9.1 million for fiscal 2015.

"Fiscal year 2016 will go down as a landmark year for the company in sales and earnings per share,” said Mark A. Le Doux, Chairman and CEO of Natural Alternatives. “On a quarterly basis, the fourth quarter also generated considerable growth in EPS. This result was achieved through the hard work of many team members of the company. We remain debt-free with a strong balance sheet and continue to seek ways of expanding our presence in the international marketplace and leading by example.”

Headquartered in San Marcos, California, Natural Alternatives provides contract manufacturing services to companies that market & distribute vitamins, minerals, herbs nutritional supplements, and other health care products both domestic and abroad. Earlier this month, the company announced the immediate availability of its Patented Sustained Release SR CarnoSyn® Beta-Alanine. This sustained release technology, according to the company’s official press release, stays in the body longer for extended absorption, provides higher muscle retention, and demonstrates a significant increase in muscle carnosine levels to extend endurance, speed muscle recovery, build muscle strength, and enhance peak performance capabilities.

"SR CarnoSyn® sustained release beta-alanine is now commercially available and provides formulation flexibility, extending the benefits of beta-alanine to a much broader group of consumers," said LeDoux. "This proprietary and patented form of beta-alanine shows tremendous market growth potential in applications for serious athletes, as well as active individuals and the healthy aging market."

Thanks to an increasingly health conscious public, vitamins, supplements, and performance enhancers are, no longer, just being sought out by professional athletes. The desire for a better quality of life and, overall, longevity has created a demand for effective and accessible wellness products. Natural Alternatives sales increases and impressive performance demonstrates the continued demand within this sector.

To learn more about Natural Alternatives, visit www.nai-online.com.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer.

Companies

Symbol Name Price Change % Volume
NAII Natural Alternatives International Inc. 9.61 0.36 3.89 6,191 Trade

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
GOOG

     
XOM

     
BRK.A

     
FB

     
JNJ

     
WFC

     
T

     
NFLX

     
TSLA

     
V

     
UNH

     
PG

     

World Economic Forum at Davos 2019 - Ben Yablon Executive VP Salt Lending

Matt Bird sits down with Ben Yablon - Executive VP of Salt Lending - at the World Economic Forum in Davos January 2019